Molecular Profiling of Pancreatic Cancer Patients-Response

Michael J Pishvaian^{1

2}, Emanuel Petricoin 3rd^{2

3}

Affiliations

¹ Lombardi Comprehensive Cancer Center, Georgetown University Medical Center Washington, D.C. pishvaim@georgetown.edu.
² Perthera, Inc, McLean, Virginia.
³ George Mason University, Fairfax, Virginia.

Comment

Michael J Pishvaian et al. Clin Cancer Res. 2018.

. 2018 Dec 15;24(24):6612.

doi: 10.1158/1078-0432.CCR-18-2645.

Michael J Pishvaian^{1

2}, Emanuel Petricoin 3rd^{2

3}

¹ Lombardi Comprehensive Cancer Center, Georgetown University Medical Center Washington, D.C. pishvaim@georgetown.edu.
² Perthera, Inc, McLean, Virginia.
³ George Mason University, Fairfax, Virginia.

No abstract available

Comment on

Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative.
Pishvaian MJ, Bender RJ, Halverson D, Rahib L, Hendifar AE, Mikhail S, Chung V, Picozzi VJ, Sohal D, Blais EM, Mason K, Lyons EE, Matrisian LM, Brody JR, Madhavan S, Petricoin EF 3rd. Pishvaian MJ, et al. Clin Cancer Res. 2018 Oct 15;24(20):5018-5027. doi: 10.1158/1078-0432.CCR-18-0531. Epub 2018 Jun 28. Clin Cancer Res. 2018. PMID: 29954777
Molecular Profiling of Pancreatic Cancer Patients-Letter.
Sahin IH, Elias H. Sahin IH, et al. Clin Cancer Res. 2018 Dec 15;24(24):6611. doi: 10.1158/1078-0432.CCR-18-2255. Clin Cancer Res. 2018. PMID: 30552236 No abstract available.